EUVIMEDEUVIMED entdecken
Crossref

Identifying an At‐Risk Asthma Phenotype: Allergy and Recurrent Infections Predict Severe Disease

Emilie Johanning Bari iD, Susanne Hansen iD, Patrik Sandin, Olivia Ernstsson, Kirk Geale, Apostolos Bossios, Lauri Lehtimäki, Christer Janson, Charlotte Ulrik iD, Hannu Kankaanranta, Bernt Bøgvald Aarli, Anna Von Bülow iD und 18 weitere

Clinical & Experimental Allergy · 2026

DOI: 10.1111/cea.70230 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical & Experimental Allergy, 2026. Verfasst von Emilie Johanning Bari und 29 weiteren Autor:innen. Beteiligte Einrichtung: Respiratory Research Unit, Department of Respiratory Medicine and Infectious Diseases, Bispebjerg Hospital, Copenhagen, Denmark. Hauptthemen laut MEDLINE: Asthma, Respiratory Tract Infections, Hypersensitivity. Die Arbeit nennt 41 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Asthma severity is influenced by complex immunologic and environmental factors. While allergic asthma is linked to increased susceptibility to respiratory infections, the combined role of allergy and antibiotic‐treated infections in progression to severe asthma has not been fully evaluated.

Objective

To evaluate whether allergic asthma and recurrent respiratory infections (RRI) requiring antibiotics are associated with increased risk of developing severe asthma.

Methods

We conducted a registry‐based cohort study using Swedish national registry data. Adults with mild‐to‐moderate asthma were identified in 2014 (baseline) based on prescription records and absence of severe disease indicators. During a two‐year exposure window (2015–2016), RRI was defined as ≥ 2 antibiotic prescriptions for lower respiratory tract infections. The outcome was development of severe asthma during 2017–2019, based on ERS/ATS treatment criteria. Allergic asthma was defined by ≥ 2 prescriptions for anti‐allergic medications at baseline.

Results

Among 113,393 patients, 24,692 (21.8%) had allergic asthma. RRI occurred more frequently in allergic versus non‐allergic asthma (7.5% vs. 5.9%, p < 0.001). A total of 869 patients (0.77%) developed severe asthma. Incidence was higher in those with RRI and highest among patients with both allergic asthma and RRI (2.0%), corresponding to a relative risk of 3.47 (95% CI: 2.49–4.83) versus patients with neither exposure. Results were consistent after adjustment for age, sex and comorbidities.

Conclusion

Allergic asthma and antibiotic‐treated respiratory infections were independent and additive predictors of severe asthma progression. These findings support a clinically actionable risk profile and may inform targeted preventive strategies in asthma management.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AsthmaRespiratory Tract InfectionsHypersensitivityHumansFemaleMaleAdultPhenotypeMiddle AgedSwedenRegistriesSeverity of Illness IndexRisk FactorsRecurrenceAnti-Bacterial AgentsAgedDisease ProgressionCohort Studies

Stichwörter der Autor:innen

allergic asthmaat‐risk asthmaepidemiologyinfectionsregistry datasevere asthma

Substanzen

Anti-Bacterial Agents

Autor:innen und Institutionen

  • Respiratory Research Unit, Department of Respiratory Medicine and Infectious Diseases, Bispebjerg Hospital, Copenhagen, Denmark.
  • Centre for Clinical Research and Prevention, Frederiksberg Hospital, Copenhagen, Denmark.
  • Quantify Research, Stockholm, Sweden.
  • Department of Learning, Informatics, Management and Ethics, Karolinska Institutet, Solna, Sweden.
  • Department of Respiratory Medicine and Allergy, Karolinska Severe Asthma Center, Karolinska University Hospital, Huddinge, Stockholm, Sweden.
  • Division of Lung and Airway Research, Institute of Environmental Medicine, and the Center for Molecular Medicine, Karolinska Institutet, Stockholm, Sweden.

ORCID-Profile: Emilie Johanning Bari, Susanne Hansen, Charlotte Ulrik, Anna Von Bülow, Helena Backman, Ole Hilberg, Paula Kauppi, Valentyna Yasinska

Zitieren

APA

Bari, E. J., Hansen, S., Sandin, P., Ernstsson, O., Geale, K., Bossios, A., Lehtimäki, L., Janson, C., Ulrik, C., Kankaanranta, H., Aarli, B. B., Von Bülow, A., Viinanen, A., Sverrild, A., Lúdvíksdóttir, D., Backman, H., Schmid, J. M., Karjalainen, J., Bjermer, L., …, & Porsbjerg, C. (2026). Identifying an At‐Risk Asthma Phenotype: Allergy and Recurrent Infections Predict Severe Disease. Clinical & Experimental Allergy. https://doi.org/10.1111/cea.70230

Vancouver

Bari EJ, Hansen S, Sandin P, Ernstsson O, Geale K, Bossios A, et al. Identifying an At‐Risk Asthma Phenotype: Allergy and Recurrent Infections Predict Severe Disease. Clinical & Experimental Allergy. 2026. doi:10.1111/cea.70230

BibTeX
@article{Bari2026,
  author = {Bari, Emilie Johanning and Hansen, Susanne and Sandin, Patrik and Ernstsson, Olivia and Geale, Kirk and Bossios, Apostolos and Lehtimäki, Lauri and Janson, Christer and Ulrik, Charlotte and Kankaanranta, Hannu and Aarli, Bernt Bøgvald and Von Bülow, Anna and Viinanen, Arja and Sverrild, Asger and Lúdvíksdóttir, Dóra and Backman, Helena and Schmid, Johannes Martin and Karjalainen, Jussi and Bjermer, Leif and Kilpeläinen, Maritta and Hilberg, Ole and Kauppi, Paula and Lehmann, Sverre and Sandström, Thomas and Skjold, Tina and Björnsdóttir, Unnur Steina and Yasinska, Valentyna and Backer, Vibeke and Altraja, Alan and Porsbjerg, Celeste},
  title = {Identifying an At‐Risk Asthma Phenotype: Allergy and Recurrent Infections Predict Severe Disease},
  journal = {Clinical & Experimental Allergy},
  year = {2026},
  doi = {10.1111/cea.70230}
}
Kostenlos starten →